| Product NDC: | 66220-729 |
| Proprietary Name: | Kristalose |
| Non Proprietary Name: | lactulose |
| Active Ingredient(s): | 20 g/20g & nbsp; lactulose |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66220-729 |
| Labeler Name: | Cumberland Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074712 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120120 |
| Package NDC: | 66220-729-30 |
| Package Description: | 30 POUCH in 1 CARTON (66220-729-30) > 20 g in 1 POUCH (66220-729-01) |
| NDC Code | 66220-729-30 |
| Proprietary Name | Kristalose |
| Package Description | 30 POUCH in 1 CARTON (66220-729-30) > 20 g in 1 POUCH (66220-729-01) |
| Product NDC | 66220-729 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lactulose |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20120120 |
| Marketing Category Name | ANDA |
| Labeler Name | Cumberland Pharmaceuticals Inc. |
| Substance Name | LACTULOSE |
| Strength Number | 20 |
| Strength Unit | g/20g |
| Pharmaceutical Classes | Osmotic Laxative [EPC],Osmotic Activity [MoA],Acidifying Activity [MoA],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |